Table 3.
Drug | Correlation | MAE | ||||||||
---|---|---|---|---|---|---|---|---|---|---|
KL divergence | Hellinger Distance | KL divergence | Hellinger Distance | |||||||
RF | FRFL | FRF | FRFL | FRF | RF | FRFL | FRF | FRFL | FRF | |
Erlotinib | 0.4408 | 0.4473 | 0.4620 | 0.4265 | 0.4643 | 0.0546 | 0.0544 | 0.0466 | 0.0552 | 0.0472 |
Nilotinib | 0.3886 | 0.4263 | 0.4601 | 0.4475 | 0.5009 | 0.0465 | 0.0459 | 0.0375 | 0.0457 | 0.0373 |
PD-0325901 | 0.4716 | 0.5149 | 0.5775 | 0.4920 | 0.5633 | 0.1353 | 0.1330 | 0.1370 | 0.1352 | 0.1386 |
PLX-4720 | 0.2957 | 0.3168 | 0.4308 | 0.3314 | 0.4491 | 0.0494 | 0.0489 | 0.0398 | 0.0492 | 0.0397 |
TAE-684 | 0.2757 | 0.3245 | 0.3689 | 0.2860 | 0.3337 | 0.0728 | 0.0723 | 0.0688 | 0.0730 | 0.0697 |
For FRFL and FRF, node cost is calculated using f-divergences (KL divergence or Hellinger distance) of the response distributions at 8 different doses. Bold values indicate the best performances.